Article
Progenitor tumours from Emu-bcl-2-myc transgenic mice have lymphomyeloid differentiation potential and reveal developmental differences in cell survival.
The EMBO journal - 1 Aug 1996
Strasser A, Elefanty A G, Harris A W, Cory S
Abstract excerpt
Mice expressing both a bcl-2 and a myc transgene within the B lymphoid cell compartment invariably develop novel immature haemopoietic tumours. The likely cell of origin of these tumours was identified by a common pattern of cell surface marker expression on a subset of cells comprising approximately 1% of normal mouse bone marrow. The bcl-2-myc tumour cells could be induced to differentiate into either B...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
